Yazar "Yildiz, F." için listeleme
-
Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide
Yilmaz, N.; Emmungil, H.; Gucenmez, S.; Ozen, G.; Yildiz, F.; Balkarli, A.; Yavuz, S. (CLINICAL & EXPER RHEUMATOLOGY, 2015)… -
Outcome in carcinoma of the uterus with papillary serous and clear cell histology: A Turkish Oncology Group Study
Yumuk, P. F.; Kucucuk, S.; Atasoy, B. M.; Aydin, A.; Cicin, I.; Yildiz, F.; Topuz, E. (AMER SOC CLINICAL ONCOLOGY, 2008)… -
Risk factors for malignancy in systemic sclerosis patients
Kasifoglu, T.; Bilge, S. Yasar; Yildiz, F.; Ozen, G.; Pehlivan, Y.; Yilmaz, N.; Onat, A. M. (SPRINGER LONDON LTD, 2016)Systemic sclerosis (SSc) is an autoimmune connective tissue disease with multisystem involvement. An increased incidence of cancer in SSc patients compared with the general population has been reported in several reports. ...